These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 24841701)
21. Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis. Bayer O; Reinhart K; Kohl M; Kabisch B; Marshall J; Sakr Y; Bauer M; Hartog C; Schwarzkopf D; Riedemann N Crit Care Med; 2012 Sep; 40(9):2543-51. PubMed ID: 22903091 [TBL] [Abstract][Full Text] [Related]
22. Is 6% tetrastarch 130kDa (hydroxyethyl starch 130/0.4 or 130/0.42) suitable for severe sepsis? Patel A; Brett SJ Br J Hosp Med (Lond); 2013 Mar; 74(3):178. PubMed ID: 23665793 [No Abstract] [Full Text] [Related]
23. Gastrointestinal morbidity as primary outcome measure in studies comparing crystalloid and colloid within a goal-directed therapy. Hunsicker O; Scott MJ; Miller TE; Baldini G; Feldheiser A Br J Anaesth; 2015 Jul; 115(1):128-9. PubMed ID: 26089448 [No Abstract] [Full Text] [Related]
24. Gastrointestinal morbidity as primary outcome measure in studies comparing crystalloid and colloid within a goal-directed therapy. Hunsicker O; Scott MJ; Miller TE; Baldini G; Feldheiser A Br J Anaesth; 2015 Jan; 114(1):160-2. PubMed ID: 25500398 [No Abstract] [Full Text] [Related]
25. New insights into fluid resuscitation. Myburgh J; McIntyre L Intensive Care Med; 2013 Jun; 39(6):998-1001. PubMed ID: 23559078 [TBL] [Abstract][Full Text] [Related]
27. Colloids and renal dysfunction: another brick in the wall of safety concerns. Erstad BL Crit Care Med; 2011 Jun; 39(6):1565-6. PubMed ID: 21610625 [No Abstract] [Full Text] [Related]
28. Individual patient data meta-analysis of hydroxyethyl starch 130/0.4-0.42 versus crystalloid for fluid resuscitation in patients with severe sepsis: a statistical analysis plan. Hammond NE; Haase N; Billot L; Wetterslev J; Saxena MK; Finfer S; Perner A; Myburgh J Crit Care Resusc; 2014 Jun; 16(2):96-103. PubMed ID: 24888279 [TBL] [Abstract][Full Text] [Related]
29. The Crystalloid versus Hydroxyethyl Starch Trial: protocol for a multi-centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Crystalloid versus Hydroxyethyl Starch Trial (CHEST) Management Committee Intensive Care Med; 2011 May; 37(5):816-23. PubMed ID: 21308360 [TBL] [Abstract][Full Text] [Related]
30. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. Brunkhorst FM; Engel C; Bloos F; Meier-Hellmann A; Ragaller M; Weiler N; Moerer O; Gruendling M; Oppert M; Grond S; Olthoff D; Jaschinski U; John S; Rossaint R; Welte T; Schaefer M; Kern P; Kuhnt E; Kiehntopf M; Hartog C; Natanson C; Loeffler M; Reinhart K; N Engl J Med; 2008 Jan; 358(2):125-39. PubMed ID: 18184958 [TBL] [Abstract][Full Text] [Related]
31. [The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock]. Lyu J; Li T; Liu F; An Y Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jan; 27(1):28-32. PubMed ID: 25591433 [TBL] [Abstract][Full Text] [Related]
32. Principles of Fluid Management. Rewa O; Bagshaw SM Crit Care Clin; 2015 Oct; 31(4):785-801. PubMed ID: 26410145 [TBL] [Abstract][Full Text] [Related]
33. Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Rochwerg B; Alhazzani W; Sindi A; Heels-Ansdell D; Thabane L; Fox-Robichaud A; Mbuagbaw L; Szczeklik W; Alshamsi F; Altayyar S; Ip WC; Li G; Wang M; Wludarczyk A; Zhou Q; Guyatt GH; Cook DJ; Jaeschke R; Annane D; Ann Intern Med; 2014 Sep; 161(5):347-55. PubMed ID: 25047428 [TBL] [Abstract][Full Text] [Related]
34. Prolonged Field Care Working Group Fluid Therapy Recommendations. Baker BL; Powell D; Riesberg J; Keenan S J Spec Oper Med; 2016; 16(1):112-7. PubMed ID: 27045508 [TBL] [Abstract][Full Text] [Related]
35. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trial. Perner A; Haase N; Wetterslev J; Aneman A; Tenhunen J; Guttormsen AB; Klemenzson G; Pott F; Bødker KD; Bådstøløkken PM; Bendtsen A; Søe-Jensen P; Tousi H; Bestle M; Pawlowicz M; Winding R; Bülow HH; Kancir C; Steensen M; Nielsen J; Fogh B; Madsen KR; Larsen NH; Carlsson M; Wiis J; Petersen JA; Iversen S; Schøidt O; Leivdal S; Berezowicz P; Pettilä V; Ruokonen E; Klepstad P; Karlsson S; Kaukonen M; Rutanen J; Karason S; Kjældgaard AL; Holst LB; Wernerman J; Trials; 2011 Jan; 12():24. PubMed ID: 21269526 [TBL] [Abstract][Full Text] [Related]
36. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. Wills BA; Nguyen MD; Ha TL; Dong TH; Tran TN; Le TT; Tran VD; Nguyen TH; Nguyen VC; Stepniewska K; White NJ; Farrar JJ N Engl J Med; 2005 Sep; 353(9):877-89. PubMed ID: 16135832 [TBL] [Abstract][Full Text] [Related]